SpliceBio

Description

SpliceBio builds protein splicing–based genetic medicines and develops therapeutics for diseases caused by mutations in large genes, including clinical-stage programs such as a lead program in Stargardt disease.

SpliceBio is located in the Barcelona ecosystem.

Related

• ALLOXALLOX uses high-throughput experiments with genetics and AI to learn biophysical parameters of protein function, supporting systematic…
• CircioCircio develops circular RNA and immunotherapy medicines, including circVec AAV gene therapy work that uses circular RNA to enhance…
• ResQ BiotechResQ Biotech builds a living-cell discovery platform that biosynthesizes and functionally screens ultra-large libraries to identify…
• FineHeartFineHeart develops FlowMaker as a therapy for advanced heart failure, creates clinical-stage cardiology technology, and leads an IPCEI…
• Constructive BioConstructive Bio designs and manufactures new-to-nature proteins using expanded genetic code and programmable cellular manufacturing for…
• BIMINI BiotechBIMINI Biotech develops first-in-class small-molecule therapeutics targeting the Wiskott–Aldrich Syndrome protein for oncology and…
• Relation TherapeuticsRelation Therapeutics develops proprietary AI and experimental platforms that combine high-resolution biology, machine learning, genetics,…
• Molecular PartnersMolecular Partners develops DARPin therapeutics, including Radio-DARPins and logic-gated Switch-DARPins, to target DLL3, FAP x CD40, and…
• NTrans TechnologiesNTrans Technologies develops a non-viral delivery platform for cell and gene therapies, providing modular delivery solutions for…